Blog

Madeline Lancaster, PhD, MRC Laboratory of Molecular Biology
Omer Yilmaz, PhD, Assistant Professor of Biology, MIT
Sri Devi Narasimhan, Scientific Editor, Cell
Marie Bao, Editor, Developmental Cell

In this webinar, brought to you by Cell Press and Bio-Techne, we bring together leading researchers that are using stem cells to create organoids for the advancement of basic biology, regenerative medicine, and personalized medicine. With the growing use of organoids for these applications, this webinar discusses the challenges of using organoids to accurately recapitulate in vivo complexity, including microenvironment cues and cellular crosstalk. Topics in this webinar include:

Topics in this showcase...

Kapil Bharti, PhD, National Eye Institute, Unit on Ocular Stem Cells and Translational Research

Induced pluripotent stem (iPS) cells are a potential source for developing autologous cell therapies. In this webinar, Dr. Kapil Bharti, provides a streamlined regulatory (cell manufacturing and preclinical) path towards filing an Investigational New Drug (IND) application to conduct a phase I clinical trial using autologous iPS cells. His group has developed a clinically compatible Good Manufacturing Practices (GMP) process to generate and functionally validate age-related macular degeneration (AMD) patient-specific iPS cell-derived retinal pigment monolayer tissue. He will discuss in-process quality controls that they have developed to monitor the entire manufacturing process and steps to validate patient-specific...